Mirum Pharmaceuticals’ $445 Million Acquisition of Travere’s Bile Acid Product Portfolio

Leila Ahmed
Tagged:

Gibson, Dunn & Crutcher LLP is advising Mirum Pharmaceuticals, Cooley LLP is advising Travere Therapeutics, Inc. in the transaction.Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) and Travere Therapeutics,…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Leila Ahmed

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here